Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial

Figure 3

Percentage of patients with OAB dry achieving ≥50% reduction from baseline in mean daily urgency episodes. ^∗ < 0.05 vs. placebo using mixed model for repeated measures.